Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-15%
Multivitamin & Multimineral [A-Z gold preparation]
-26%
Cefixime
-23%
Opsonin Pharmaceuticals Ltd.
-24%
NIPRO JMI Pharmaceuticals Ltd.
-13%
Esomeprazole
-35%
Esomeprazole
-33%
Ceftriaxone Sodium
-18%
Ibn Sina Pharmaceuticals Ltd.